Drug Shortage Report for MAR-GABAPENTIN

Last updated on 2018-04-25 History
Report ID 899
Drug Identification Number 02391473
Brand name MAR-GABAPENTIN
Common or Proper name MAR-Gabapentin
Company Name MARCAN PHARMACEUTICALS INC
Market Status DORMANT
Active Ingredient(s) GABAPENTIN
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 500 Capsule
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2017-03-13
Actual start date 2017-04-01
Estimated end date 2018-05-01
Actual end date 2018-04-24
Shortage status Resolved
Updated date 2018-04-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2 GURDWARA RD., SUITE 112
OTTAWA, ONTARIO
CANADA K2E 1A2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-04-25 English Compare
v9 2018-04-24 French Compare
v8 2018-04-24 English Compare
v7 2017-11-23 French Compare
v6 2017-11-23 English Compare
v5 2017-11-23 French Compare
v4 2017-11-23 English Compare
v3 2017-03-14 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 10 of 10